Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Doctor asking questions to patient about care
Rare Factor X Deficiency Survey Shows Disparity in Care
Press Releases
bdc award winners 2022
NHF Announces its Awards of Excellence 2022 Winners
Industry
Gene Helix for Gene Therapy Image
BioMarin Receives Conditional Approval in Europe for Gene Therapy
Medical
NBDF and HFA Address Concerns on WHO's Recommendation of Cryoprecipitate
PPTA Posts Statement on Monkeypox and Plasma Protein Therapies
Industry
BioMarin Presents Abstract on Vector DNA Transmission Risk at ISTH
BioMarin Presents Abstract on Vector DNA Transmission Risk at ISTH
Industry
New Prophylaxis Approval for REBINYN®
New Prophylaxis Approval for REBINYN®
Peer-Reviewed Journal Summaries
Gene Therapy Helix
Paper Features Q&A Resource on Shared Decision Making and Gene Therapy
Industry
Sanofi Provides Fitusiran Trial Updates at ISTH
Sanofi Provides Fitusiran Trial Updates at ISTH
Industry
Prophylactic Therapy for Glanzmann Thrombasthenia Moves Towards Clinical Trials
Prophylactic Therapy for Glanzmann Thrombasthenia Moves Towards…
Industry
Scientist using Microscope in a clinical trial
Sanofi and Sobi® Report Progress with BIVV001 at International Congress
Advocacy & Legislative
NHF Addresses Potential Contraception Bans
NBDF & Community
NHF Employee Highlight - Meet Nick Kallinicou!
Medical
New Genotyping Recommendations Issued by MASAC
Press Releases
NHF launches new Research Fund in honor of Dr. Marion Koerper
Press Releases
Bleeding Disorders Conference
Most Impactful Meeting in IBD Community Heads to Houston This August